brequinar has been researched along with Bladder Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, W; Chen, X; Ding, Q; Ding, Y; Guo, H; Li, X; Mo, W; Su, Z; Tang, W; Wang, X; Zhang, Q | 1 |
1 other study(ies) available for brequinar and Bladder Cancer
| Article | Year |
|---|---|
Mitochondrial-targeted brequinar liposome boosted mitochondrial-related ferroptosis for promoting checkpoint blockade immunotherapy in bladder cancer.
Topics: CD8-Positive T-Lymphocytes; Cell Line, Tumor; Ferroptosis; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Liposomes; Mitochondria; Tumor Microenvironment; Urinary Bladder Neoplasms | 2023 |